Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
复制标题
DOI：
10.1007/s00125-008-1157-y
复制
发表时间：
2009-01-01
期刊：
影响因子：
8.2
通讯作者：
Zinman, B.
中科院分区：
文献类型：
--
作者：
Nathan, D. M.;Buse, J. B.;Zinman, B.
2 型糖尿病医疗管理的共识算法于 2006 年 8 月发布，预计将根据新干预措施和确立其临床作用的新证据的可用性进行更新。作者继续认可用于开发该算法的原则及其主要功能。我们对在没有令人信服的新信息的情况下随意或过于频繁地改变算法的风险很敏感。 2008 年 1 月发布的共识算法更新专门解决了与噻唑烷二酮类相关的安全问题。在本次修订中，我们重点关注现在拥有更多临床数据和经验的新类别药物。
The consensus algorithm for the medical management of type 2 diabetes was published in August 2006 with the expectation that it would be updated, based on the availability of new interventions and new evidence to establish their clinical role. The authors continue to endorse the principles used to develop the algorithm and its major features. We are sensitive to the risks of changing the algorithm cavalierly or too frequently, without compelling new information. An update to the consensus algorithm published in January 2008 specifically addressed safety issues surrounding the thiazolidinediones. In this revision, we focus on the new classes of medications that now have more clinical data and experience.